SHENZHEN, China, April 16, 2013 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the first quarter ended March 31, 2013 after the U.S. market closes on May 6, 2013. Mindray's management will hold an earnings conference call at 8:00 AM on May 7, 2013 U.S. Eastern Time ( 8:00 PM on May 7, 2013 Beijing/Hong Kong Time).
Dial-in details for the earnings conference call are as follows:
International Toll Free:
United States: +1-866-519-4004 Hong Kong: 800-930-346China Landline: 800-819-0121Local dial-in numbers: United States: +1-718-354-1231 Hong Kong: +852-2475-0994China Mobile: 400-620-8038 Passcode for all regions: Mindray A replay of the conference call may be accessed by phone at the following numbers until May 22, 2013. U.S. Toll Free: +1-855-452-5696International: +1-646-254-3697Passcode: 36769828 Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray's website at: http://ir.mindray.com/ About Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com. For investor and media inquiries, please contact: In the U.S.: Hoki LukWestern Bridge, LLCTel: +1-646-808-9150Email: firstname.lastname@example.org In China: Cathy Gao Mindray Medical International LimitedTel: +86-755-8188-8023Email: email@example.com SOURCE Mindray Medical International Limited
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts